Novo Nordisk A/S ADR buy StockNews.com
Start price
21.12.24
/
50%
€84.00
Target price
21.12.25
-
Performance (%)
-41.37%
Price
15:01
€48.15
Summary
This prediction is currently active. The BUY prediction by StockNews_com for Novo Nordisk A/S ADR is performing very badly with a performance of -41.37%. Dividends of €1.10 are taken into consideration when calculating the performance. This prediction currently runs until 21.12.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 0.412% | 0.412% |
| iShares Core DAX® | -2.076% | 0.349% |
| iShares Nasdaq 100 | -0.913% | 2.076% |
| iShares Nikkei 225® | -1.337% | 3.970% |
| iShares S&P 500 | -0.677% | 2.721% |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NVO provided by MarketBeat